Support Groups

LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg are prescribed for the palliative treatment of advanced prostate cancer.

An increase in urinary symptoms and/or pain may occur during the first few weeks of LUPRON DEPOT treatment. In patients whose cancer has spread to the spine or urinary tract, urinary blockage or pressure in the spine may occur and can lead to paralysis, which may be fatal. LUPRON DEPOT may cause impotence. Females who are or may become pregnant should not receive LUPRON DEPOT.

Please click here for additional Important Safety Information you should know about LUPRON DEPOT and discuss with your doctor.

CANCERFACTS.COM

www.cancerfacts.com/Home_SupportGroups.asp
Cancerfacts.com provides a locator page to search for prostate cancer support groups by state.

MAN TO MAN
(800) ACS-2345

http://www.cancer.org/docroot/ESN/content/ESN_3_1x_Man_to_Man_36.asp?sitearea=SHR
Sponsored by the American Cancer Society, Man to Man offers group education, discussion and support for men with prostate cancer. Volunteer coordinators invite speakers, publicize meeting schedules and make local arrangements for monthly meetings. To find out if these services are available in your area, contact your local ACS office or call (800) ACS-2345.

US TOO Prostate Cancer Education and Support
(800) 808-7866

www.ustoo.com
US TOO helps survivors of prostate cancer and prostate disease and their families lead healthy and productive lives. This organization offers fellowship, shared counseling, and discussion sessions in both formal and informal settings.


Use and Important Safety Information you should know about Lupron Depot® (leuprolide acetate for depot suspension)


Use

LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg are prescribed for the palliative treatment of advanced prostate cancer.

Important Safety Information

Do not take LUPRON DEPOT if you have experienced any type of allergic reaction to LUPRON DEPOT or similar drugs.

LUPRON DEPOT 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg should not be used in women.

An increase in testosterone will generally occur during the first few weeks of therapy. In some men, this may cause a temporary increase in urinary symptoms and/or pain. If your cancer has spread to the spine or urinary tract, you may require close medical attention during the first few weeks of therapy. You should also know that LUPRON DEPOT may cause impotence. You should notify your doctor if you develop any new or worsened symptoms after beginning LUPRON DEPOT treatment.

It is recommended that your PSA and serum testosterone levels be monitored at regular intervals.

The most common side effects of LUPRON DEPOT include hot flashes or sweats, injection site reactions, general pain, edema, testicular atrophy, urinary disorders, joint disorder and GI disorders.

LUPRON DEPOT must be administered in your doctor’s office.

This is the most important information to know about LUPRON DEPOT. For more information, talk with your health care provider.

Reference: LUPRON DEPOT 7.5 mg, −3 Month 22.5 mg and −4 Month 30 mg [package insert]. North Chicago, IL: Abbott Laboratories.

Please see the complete Prescribing Information for Lupron Depot.

Lupron Depot is available by prescription only.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
If you cannot afford your medication, contact www.pparx.org or call the
toll-free phone number (1-888-4PPA-NOW) (1-888-477-2669) for assistance.

200-263312